The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine. We evaluated the Mo...
Main Authors: | Frances E Tiffin-Richards, Ana S Costa, Bernhard Holschbach, Rolf D Frank, Athina Vassiliadou, Thilo Krüger, Karl Kuckuck, Theresa Gross, Frank Eitner, Jürgen Floege, Jörg B Schulz, Kathrin Reetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4209968?pdf=render |
Similar Items
-
Increased cerebral water content in hemodialysis patients.
by: Kathrin Reetz, et al.
Published: (2015-01-01) -
Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis
by: Sebastian Corral, et al.
Published: (2024-06-01) -
Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.
by: Susanne Angermann, et al.
Published: (2017-01-01) -
Psychometric Properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's Disease Patients in Isfahan
by: Golita Emsaki, et al.
Published: (2011-12-01) -
Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis
by: Edoardo Nicolò Aiello, et al.
Published: (2022-09-01)